Concepts (187)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Benzo(a)pyrene | 1 | 2024 | 4 | 0.850 |
Why?
|
| Cytochrome P-450 CYP1B1 | 1 | 2024 | 8 | 0.850 |
Why?
|
| Employment | 1 | 2021 | 49 | 0.650 |
Why?
|
| Medication Adherence | 1 | 2021 | 48 | 0.640 |
Why?
|
| Veterans | 1 | 2021 | 69 | 0.630 |
Why?
|
| Multiple Sclerosis | 1 | 2021 | 92 | 0.620 |
Why?
|
| Signal Transduction | 2 | 2024 | 1502 | 0.550 |
Why?
|
| Brain Ischemia | 3 | 2022 | 89 | 0.460 |
Why?
|
| Pancreatic Neoplasms | 4 | 2022 | 556 | 0.450 |
Why?
|
| Stroke | 3 | 2021 | 261 | 0.380 |
Why?
|
| Polycyclic Aromatic Hydrocarbons | 2 | 2022 | 9 | 0.350 |
Why?
|
| Firefighters | 2 | 2022 | 8 | 0.350 |
Why?
|
| Air Pollutants, Occupational | 2 | 2022 | 14 | 0.350 |
Why?
|
| Occupational Exposure | 2 | 2022 | 29 | 0.340 |
Why?
|
| Cachexia | 2 | 2022 | 53 | 0.340 |
Why?
|
| Humans | 27 | 2024 | 29216 | 0.330 |
Why?
|
| Diabetes, Gestational | 2 | 2022 | 73 | 0.320 |
Why?
|
| Subarachnoid Hemorrhage | 2 | 2022 | 60 | 0.320 |
Why?
|
| Diabetes Mellitus | 2 | 2020 | 216 | 0.260 |
Why?
|
| Transcriptome | 2 | 2024 | 244 | 0.220 |
Why?
|
| Interferon-beta | 2 | 2022 | 40 | 0.210 |
Why?
|
| Hydrocephalus | 2 | 2022 | 56 | 0.210 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2024 | 35 | 0.210 |
Why?
|
| Thrombectomy | 2 | 2020 | 30 | 0.190 |
Why?
|
| Amino Acids | 2 | 2022 | 85 | 0.190 |
Why?
|
| Metabolomics | 2 | 2022 | 89 | 0.180 |
Why?
|
| Parabens | 1 | 2022 | 5 | 0.180 |
Why?
|
| Acetate-CoA Ligase | 1 | 2022 | 9 | 0.180 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2022 | 39 | 0.180 |
Why?
|
| Lung Injury | 1 | 2022 | 34 | 0.170 |
Why?
|
| Communicable Diseases | 1 | 2022 | 21 | 0.170 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2022 | 43 | 0.170 |
Why?
|
| Influenza A virus | 1 | 2022 | 40 | 0.170 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2022 | 42 | 0.170 |
Why?
|
| Antigens, CD | 1 | 2022 | 143 | 0.170 |
Why?
|
| Transforming Growth Factor beta | 1 | 2022 | 79 | 0.170 |
Why?
|
| Pneumonia | 1 | 2022 | 89 | 0.170 |
Why?
|
| Fires | 1 | 2021 | 12 | 0.170 |
Why?
|
| Arsenicals | 1 | 2021 | 5 | 0.170 |
Why?
|
| Hyperglycemia | 1 | 2022 | 79 | 0.170 |
Why?
|
| MicroRNAs | 2 | 2022 | 305 | 0.170 |
Why?
|
| Arsenic | 1 | 2021 | 21 | 0.170 |
Why?
|
| Cell Plasticity | 1 | 2021 | 11 | 0.170 |
Why?
|
| Adenosine | 1 | 2021 | 33 | 0.160 |
Why?
|
| Clinical Decision-Making | 1 | 2021 | 63 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2022 | 158 | 0.160 |
Why?
|
| Colonic Neoplasms | 1 | 2022 | 122 | 0.160 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2021 | 26 | 0.160 |
Why?
|
| Solute Carrier Organic Anion Transporter Family Member 1B3 | 1 | 2021 | 21 | 0.160 |
Why?
|
| Influenza, Human | 1 | 2022 | 101 | 0.160 |
Why?
|
| Colorectal Neoplasms | 1 | 2022 | 143 | 0.160 |
Why?
|
| Cell Line, Tumor | 5 | 2022 | 1362 | 0.160 |
Why?
|
| Endometrial Neoplasms | 1 | 2022 | 189 | 0.160 |
Why?
|
| Cigarette Smoking | 1 | 2022 | 86 | 0.160 |
Why?
|
| Zinc | 1 | 2021 | 63 | 0.160 |
Why?
|
| Mental Health | 1 | 2021 | 111 | 0.160 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2021 | 123 | 0.160 |
Why?
|
| Cell Culture Techniques | 1 | 2021 | 117 | 0.160 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 124 | 0.150 |
Why?
|
| Hepatocytes | 1 | 2021 | 97 | 0.150 |
Why?
|
| Carotid Artery Thrombosis | 1 | 2019 | 4 | 0.150 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2019 | 16 | 0.150 |
Why?
|
| Adenocarcinoma | 1 | 2022 | 301 | 0.150 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2021 | 163 | 0.150 |
Why?
|
| Disease Management | 1 | 2020 | 91 | 0.150 |
Why?
|
| Time-to-Treatment | 1 | 2019 | 33 | 0.150 |
Why?
|
| Pilot Projects | 4 | 2022 | 467 | 0.150 |
Why?
|
| Cell Movement | 1 | 2021 | 378 | 0.140 |
Why?
|
| Smokers | 1 | 2020 | 129 | 0.140 |
Why?
|
| Neoplasm Proteins | 1 | 2019 | 123 | 0.140 |
Why?
|
| Endovascular Procedures | 1 | 2019 | 77 | 0.140 |
Why?
|
| DNA Damage | 1 | 2019 | 153 | 0.140 |
Why?
|
| Membrane Proteins | 1 | 2022 | 489 | 0.140 |
Why?
|
| Models, Biological | 1 | 2021 | 471 | 0.140 |
Why?
|
| Biomarkers | 4 | 2022 | 790 | 0.140 |
Why?
|
| Transcription, Genetic | 1 | 2019 | 406 | 0.130 |
Why?
|
| Lung Neoplasms | 1 | 2022 | 360 | 0.130 |
Why?
|
| Liver | 1 | 2021 | 497 | 0.130 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2019 | 285 | 0.130 |
Why?
|
| Transcription Factors | 1 | 2021 | 524 | 0.130 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 847 | 0.120 |
Why?
|
| Brain | 1 | 2021 | 774 | 0.110 |
Why?
|
| Female | 8 | 2022 | 15827 | 0.100 |
Why?
|
| Ovarian Neoplasms | 1 | 2019 | 610 | 0.100 |
Why?
|
| Prospective Studies | 3 | 2022 | 1288 | 0.100 |
Why?
|
| Neoplasms | 1 | 2022 | 888 | 0.090 |
Why?
|
| Mice | 4 | 2022 | 4870 | 0.090 |
Why?
|
| Muscles | 2 | 2022 | 73 | 0.090 |
Why?
|
| DNA Copy Number Variations | 2 | 2022 | 36 | 0.090 |
Why?
|
| Cerebral Infarction | 2 | 2022 | 26 | 0.080 |
Why?
|
| Risk Factors | 3 | 2022 | 2144 | 0.080 |
Why?
|
| Retrospective Studies | 3 | 2022 | 2664 | 0.080 |
Why?
|
| Animals | 5 | 2022 | 10806 | 0.080 |
Why?
|
| Male | 6 | 2022 | 14128 | 0.080 |
Why?
|
| Treatment Outcome | 3 | 2021 | 2442 | 0.080 |
Why?
|
| Case-Control Studies | 2 | 2022 | 741 | 0.080 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 484 | 0.070 |
Why?
|
| Lung | 2 | 2022 | 389 | 0.070 |
Why?
|
| Middle Aged | 4 | 2021 | 7496 | 0.070 |
Why?
|
| Prognosis | 2 | 2020 | 817 | 0.060 |
Why?
|
| Pregnancy | 2 | 2022 | 1260 | 0.060 |
Why?
|
| Phenol | 1 | 2022 | 7 | 0.050 |
Why?
|
| Dynamin II | 1 | 2022 | 13 | 0.050 |
Why?
|
| Tumor Necrosis Factors | 1 | 2022 | 15 | 0.050 |
Why?
|
| Adenosine Monophosphate | 1 | 2022 | 21 | 0.050 |
Why?
|
| Dextrans | 1 | 2022 | 23 | 0.050 |
Why?
|
| Syndecan-1 | 1 | 2022 | 13 | 0.050 |
Why?
|
| Phenols | 1 | 2022 | 22 | 0.050 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2022 | 43 | 0.050 |
Why?
|
| Pregnant Women | 1 | 2022 | 22 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2022 | 83 | 0.050 |
Why?
|
| Genomic Instability | 1 | 2022 | 34 | 0.050 |
Why?
|
| Receptors, Growth Factor | 1 | 2022 | 7 | 0.050 |
Why?
|
| Integrins | 1 | 2022 | 29 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2022 | 103 | 0.040 |
Why?
|
| Blood Volume | 1 | 2022 | 9 | 0.040 |
Why?
|
| Sphingolipids | 1 | 2022 | 20 | 0.040 |
Why?
|
| Environmental Monitoring | 1 | 2022 | 69 | 0.040 |
Why?
|
| Cyclin D1 | 1 | 2022 | 38 | 0.040 |
Why?
|
| Hospitals | 1 | 2022 | 77 | 0.040 |
Why?
|
| Lysosomes | 1 | 2022 | 56 | 0.040 |
Why?
|
| Tobacco | 1 | 2022 | 87 | 0.040 |
Why?
|
| Lymphocytes | 1 | 2022 | 96 | 0.040 |
Why?
|
| China | 1 | 2021 | 64 | 0.040 |
Why?
|
| Research | 1 | 2022 | 93 | 0.040 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2021 | 36 | 0.040 |
Why?
|
| Infusions, Intravenous | 1 | 2021 | 102 | 0.040 |
Why?
|
| Cacodylic Acid | 1 | 2021 | 5 | 0.040 |
Why?
|
| Methylation | 1 | 2021 | 24 | 0.040 |
Why?
|
| Sincalide | 1 | 2021 | 4 | 0.040 |
Why?
|
| Language | 1 | 2021 | 66 | 0.040 |
Why?
|
| Cerebral Hemorrhage | 1 | 2022 | 94 | 0.040 |
Why?
|
| Thrombolytic Therapy | 1 | 2021 | 41 | 0.040 |
Why?
|
| Integrin alpha3 | 1 | 2021 | 18 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2021 | 95 | 0.040 |
Why?
|
| Brain Infarction | 1 | 2020 | 10 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2021 | 58 | 0.040 |
Why?
|
| Fibrinolytic Agents | 1 | 2021 | 72 | 0.040 |
Why?
|
| ROC Curve | 1 | 2021 | 144 | 0.040 |
Why?
|
| Adenoviridae | 1 | 2021 | 68 | 0.040 |
Why?
|
| Rats, Wistar | 1 | 2021 | 153 | 0.040 |
Why?
|
| Spheroids, Cellular | 1 | 2021 | 53 | 0.040 |
Why?
|
| Lipids | 1 | 2022 | 220 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2021 | 226 | 0.040 |
Why?
|
| Infarction | 1 | 2020 | 8 | 0.040 |
Why?
|
| Proteomics | 1 | 2022 | 200 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2021 | 191 | 0.040 |
Why?
|
| Genetic Vectors | 1 | 2021 | 119 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2021 | 288 | 0.040 |
Why?
|
| Cation Transport Proteins | 1 | 2021 | 60 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2021 | 165 | 0.040 |
Why?
|
| African Americans | 1 | 2022 | 353 | 0.040 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2020 | 26 | 0.040 |
Why?
|
| Histone Deacetylase 1 | 1 | 2019 | 10 | 0.040 |
Why?
|
| Vasospasm, Intracranial | 1 | 2020 | 18 | 0.040 |
Why?
|
| Histone Deacetylase 2 | 1 | 2019 | 10 | 0.040 |
Why?
|
| Hyperlipidemias | 1 | 2020 | 38 | 0.040 |
Why?
|
| Survivors | 1 | 2020 | 40 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2021 | 382 | 0.040 |
Why?
|
| Aged | 2 | 2020 | 5649 | 0.040 |
Why?
|
| Carotid Artery, Internal | 1 | 2019 | 19 | 0.040 |
Why?
|
| Needs Assessment | 1 | 2020 | 57 | 0.040 |
Why?
|
| Embolization, Therapeutic | 1 | 2020 | 52 | 0.040 |
Why?
|
| Registries | 1 | 2022 | 399 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2021 | 271 | 0.040 |
Why?
|
| Acute Disease | 1 | 2020 | 158 | 0.040 |
Why?
|
| Middle Cerebral Artery | 1 | 2019 | 56 | 0.040 |
Why?
|
| Histones | 1 | 2019 | 96 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2021 | 171 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 468 | 0.040 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2021 | 153 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2020 | 274 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2022 | 828 | 0.040 |
Why?
|
| Prevalence | 1 | 2020 | 526 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2019 | 586 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 432 | 0.030 |
Why?
|
| Sex Factors | 1 | 2019 | 473 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 473 | 0.030 |
Why?
|
| Age Factors | 1 | 2019 | 740 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 1033 | 0.030 |
Why?
|
| Inflammation | 1 | 2022 | 672 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2022 | 1684 | 0.030 |
Why?
|
| Smoking | 1 | 2020 | 480 | 0.030 |
Why?
|
| Child | 1 | 2022 | 2354 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2020 | 643 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 2070 | 0.030 |
Why?
|
| Adult | 1 | 2020 | 8130 | 0.020 |
Why?
|